Table 1.
The clinical characteristics of 181 patients with locally advanced gastric cancer
| Characteristics | Case (%) | Mean (SD) | Range |
|---|---|---|---|
| Gender | |||
| Male | 134(74.03) | ||
| Female | 47(25.97) | ||
| Age (years) | 59.0 ± 8.9 | 44–75 | |
| ≤ 60.0 | 92(50.83) | ||
| >60.0 | 89(49.17) | ||
| BMI (Kg/m 2 ) | 27.8 ± 9.2 | 18.7–37.6 | |
| ≤ 25 | 89(49.16) | ||
| >25 | 92(50.83) | ||
| ASA-PS | |||
| I | 152(83.70) | ||
| II | 29(16.30) | ||
| ECOG performance status | |||
| 0 | 164(90.61) | ||
| 1 | 17(9.39) | ||
| Tumor size (cm) | 5.8 ± 1.6 | 2.1–9.6 | |
| < 5.0 | 54(29.83) | ||
| ≥ 5.0 | 127(70.17) | ||
| Lesion site | |||
| Up 1/3 | 76(41.99) | ||
| Middle 1/3 | 25(13.81) | ||
| Low 1/3 | 80(44.20) | ||
| Differentiation | |||
| Poor | 112(61.88) | ||
| Moderately or well | 69(38.12) | ||
| cT stage | |||
| T2 | 16(8.84) | ||
| T3 | 46(25.41) | ||
| T4 | 119(65.75) | ||
| cN stage | |||
| N0 | 36(19.89) | ||
| N1 | 35(19.34) | ||
| N2 | 53(29.28) | ||
| N3 | 57(31.49) | ||
| cTNM stage | |||
| II | 53(29.28) | ||
| III | 128(70.72) | ||
| Chemotherapy regimen | |||
| XELOX | 94(51.93) | ||
| SOX | 87(48.07) | ||
| Extent of surgical resection | |||
| Distal subtotal gastrectomy | 69(38.12) | ||
| Total gastrectomy | 92(50.83) | ||
| Proximal subtotal gastrectomy | 20(11.05) | ||
| Surgical Procedures | |||
| Laparoscopic | 120(66.30) | ||
| Laparotomy | 61(33.70) | ||
Pre-treatment SII ( ±s)
|
467.3 ± 405.8 | 75.1–2247.0 | |
Pre-treatment PNI ( ±s)
|
52.9 ± 6.1 | 36.0-68.5 | |
Post-treatment SII ( ±s)
|
197.8 ± 120.5 | 47.5-773.2 | |
Post-treatment PNI ( ±s)
|
49.0 ± 5.5 | 35.0-64.1 |
Note ECOG, Eastern Cooperative Oncology Group; SII, Systemic immune-inflammatory index; PNI, Prognostic nutritional index. ASA-PS: American society of Aneshesiologists physical status classification system